Бензидамін (Ukrainian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Бензидамін" in Ukrainian language version.

refsWebsite

Global rank Ukrainian rank

11nih.gov

4^th place

5^th place

7doi.org

2^nd place

4^th place

2archive.org

6^th place

1diff.org

low place

1sussex.ac.uk

6,651^st place

low place

archive.org

Anand JS, Glebocka ML, Korolkiewicz RP (2007). Recreational abuse with benzydamine hydrochloride (tantum rosa). Clinical Toxicology. 45 (2): 198—9. doi:10.1080/15563650600981210. PMID 17364645.
Baldock GA, Brodie RR, Chasseaud LF, Taylor T, Walmsley LM, Catanese B (October 1991). Pharmacokinetics of benzydamine after intravenous, oral, and topical doses to human subjects. Biopharmaceutics & Drug Disposition. 12 (7): 481—92. doi:10.1002/bdd.2510120702. PMID 1932611.

diff.org

flipper.diff.org

DEXTROMETHORPHAN AND BENZYDAMINE'S USE AND MISUSE. Flipper.diff.org. Процитовано 25 червня 2022.

doi.org

Anand JS, Glebocka ML, Korolkiewicz RP (2007). Recreational abuse with benzydamine hydrochloride (tantum rosa). Clinical Toxicology. 45 (2): 198—9. doi:10.1080/15563650600981210. PMID 17364645.
Opaleye ES, Noto AR, Sanchez Z, Moura YG, Galduróz JC, Carlini EA (September 2009). Recreational use of benzydamine as a hallucinogen among street youth in Brazil. Revista Brasileira de Psiquiatria. 31 (3): 208—13. doi:10.1590/S1516-44462009000300005. PMID 19784487.
Mota DM, Costa AA, Teixeira C, Bastos AA, Dias MF (May 2010). Use abusive of benzydamine in Brazil: an overview in pharmacovigilance. Ciencia & Saude Coletiva (порт.). 15 (3): 717—24. doi:10.1590/S1413-81232010000300014. PMID 20464184.
Avvisati R, Meringolo M, Stendardo E, Malavasi E, Marinelli S, Badiani A (March 2018). Intravenous self-administration of benzydamine, a non-steroidal anti-inflammatory drug with a central cannabinoidergic mechanism of action (PDF). Addiction Biology. 23 (2): 610—619. doi:10.1111/adb.12516. PMID 28429885.
Baldock GA, Brodie RR, Chasseaud LF, Taylor T, Walmsley LM, Catanese B (October 1991). Pharmacokinetics of benzydamine after intravenous, oral, and topical doses to human subjects. Biopharmaceutics & Drug Disposition. 12 (7): 481—92. doi:10.1002/bdd.2510120702. PMID 1932611.
Palazzo G, Corsi G, Baiocchi L, Silvestrini B (January 1966). Synthesis and pharmacological properties of 1-substituted 3-dimethylaminoalkoxy-1H-indazoles. Journal of Medicinal Chemistry. 9 (1): 38—41. doi:10.1021/jm00319a009. PMID 5958958.
Fanaki NH, el-Nakeeb MA (December 1992). Antimicrobial activity of benzydamine, a non-steroid anti-inflammatory agent. Journal of Chemotherapy. 4 (6): 347—52. doi:10.1080/1120009X.1992.11739190. PMID 1287137.

nih.gov

pubmed.ncbi.nlm.nih.gov

Turnbull RS (February 1995). Benzydamine Hydrochloride (Tantum) in the management of oral inflammatory conditions. Journal. 61 (2): 127—34. PMID 7600413.
Anand JS, Glebocka ML, Korolkiewicz RP (2007). Recreational abuse with benzydamine hydrochloride (tantum rosa). Clinical Toxicology. 45 (2): 198—9. doi:10.1080/15563650600981210. PMID 17364645.
Opaleye ES, Noto AR, Sanchez Z, Moura YG, Galduróz JC, Carlini EA (September 2009). Recreational use of benzydamine as a hallucinogen among street youth in Brazil. Revista Brasileira de Psiquiatria. 31 (3): 208—13. doi:10.1590/S1516-44462009000300005. PMID 19784487.
Mota DM, Costa AA, Teixeira C, Bastos AA, Dias MF (May 2010). Use abusive of benzydamine in Brazil: an overview in pharmacovigilance. Ciencia & Saude Coletiva (порт.). 15 (3): 717—24. doi:10.1590/S1413-81232010000300014. PMID 20464184.
Müller-Peddinghaus R (May 1987). New pharmacologic and biochemical findings on the mechanism of action of the non-steroidal antiphlogistic, benzydamine. A synopsis. Arzneimittel-Forschung (German) . 37 (5A): 635—45. PMID 3304305.
Avvisati R, Meringolo M, Stendardo E, Malavasi E, Marinelli S, Badiani A (March 2018). Intravenous self-administration of benzydamine, a non-steroidal anti-inflammatory drug with a central cannabinoidergic mechanism of action (PDF). Addiction Biology. 23 (2): 610—619. doi:10.1111/adb.12516. PMID 28429885.
Baldock GA, Brodie RR, Chasseaud LF, Taylor T, Walmsley LM, Catanese B (October 1991). Pharmacokinetics of benzydamine after intravenous, oral, and topical doses to human subjects. Biopharmaceutics & Drug Disposition. 12 (7): 481—92. doi:10.1002/bdd.2510120702. PMID 1932611.
Maamer M, Aurousseau M, Colau JC (1987). Concentration of benzydamine in vaginal mucosa following local application: an experimental and clinical study. International Journal of Tissue Reactions. 9 (2): 135—45. PMID 3610512.
Palazzo G, Corsi G, Baiocchi L, Silvestrini B (January 1966). Synthesis and pharmacological properties of 1-substituted 3-dimethylaminoalkoxy-1H-indazoles. Journal of Medicinal Chemistry. 9 (1): 38—41. doi:10.1021/jm00319a009. PMID 5958958.
Fanaki NH, el-Nakeeb MA (December 1992). Antimicrobial activity of benzydamine, a non-steroid anti-inflammatory agent. Journal of Chemotherapy. 4 (6): 347—52. doi:10.1080/1120009X.1992.11739190. PMID 1287137.
Fanaki NH, El-Nakeeb MA (March 1996). Antibacterial activity of benzydamine and antibiotic-benzydamine combinations against multifold resistant clinical isolates. Arzneimittel-Forschung. 46 (3): 320—3. PMID 8901158.

sussex.ac.uk

sro.sussex.ac.uk

Avvisati R, Meringolo M, Stendardo E, Malavasi E, Marinelli S, Badiani A (March 2018). Intravenous self-administration of benzydamine, a non-steroidal anti-inflammatory drug with a central cannabinoidergic mechanism of action (PDF). Addiction Biology. 23 (2): 610—619. doi:10.1111/adb.12516. PMID 28429885.